Protective role of hypoxia-inducible factor-1α-dependent CD39 and CD73 in fulminant acute liver failure

    loading  Checking for direct PDF access through Ovid


Acute liver failure (ALF) is a severe life-threatening disease which usually arises in patients with-irreversible liver illnesses. Although human ectonucleotide triphosphate diphosphohydrolase-1, E-NTPDase1 (CD39) and ecto-5′-nucleotidase, Ecto5′NTase (CD73) are known to protect tissues from ALF, the expression and function of CD39 and CD73 during ALF are currently not fully investigated. We tested whether CD39 and CD73 are upregulated by hypoxia inducible factor (HIF)-1α, and improve ischemic tolerance to ALF. To test our hypothesis, liver biopsies were obtained and we found that CD39 and CD73 mRNA and proteins from human specimens were dramatically elevated in ALF. We investigated that induction of CD39 and CD73 in ALF-related with wild type mice. In contrast, deletion of cd39 and cd73 mice has severe ALF. In this study, we concluded that CD39 and CD73 are molecular targets for the development of drugs for ALF patients care.Graphical abstractHighlightsHIF-1a is stabilized during acute liver failureUpregulation of CD39 and CD73 following acute liver failureCD39 and CD73 are transcriptionally induced by HIF-1aDeletion of Cd39 and CD73 aggravates murine acute liver failureDMOG treatment induces HIF-1a stabilization, CD39 and CD73 during acute liver failure in WT mice

    loading  Loading Related Articles